These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8592119)

  • 41. Thiolic antioxidants protect from nitric oxide-induced toxicity in fetal midbrain cultures.
    Rodríguez-Martín E; Casarejos MJ; Canals S; de Bernardo S; Mena MA
    Neuropharmacology; 2002 Oct; 43(5):877-88. PubMed ID: 12384173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxidative stress during energy impairment in mesencephalic cultures is not a downstream consequence of a secondary excitotoxicity.
    Zeevalk GD; Bernard LP; Nicklas WJ
    Neuroscience; 2000; 96(2):309-16. PubMed ID: 10683571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glia conditioned medium protects fetal rat midbrain neurones in culture from L-DOPA toxicity.
    Mena MA; Casarejos MJ; Carazo A; Paino CL; García de Yébenes J
    Neuroreport; 1996 Jan; 7(2):441-5. PubMed ID: 8730801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro.
    Werner P; Di Rocco A; Prikhojan A; Rempel N; Bottiglieri T; Bressman S; Yahr MD
    Brain Res; 2001 Mar; 893(1-2):278-81. PubMed ID: 11223018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective effects of riluzole on dopamine neurons: involvement of oxidative stress and cellular energy metabolism.
    Storch A; Burkhardt K; Ludolph AC; Schwarz J
    J Neurochem; 2000 Dec; 75(6):2259-69. PubMed ID: 11080177
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pergolide protects dopaminergic neurons in primary culture under stress conditions.
    Gille G; Rausch WD; Hung ST; Moldzio R; Janetzky B; Hundemer HP; Kolter T; Reichmann H
    J Neural Transm (Vienna); 2002 May; 109(5-6):633-43. PubMed ID: 12111455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Parkin deficiency increases the resistance of midbrain neurons and glia to mild proteasome inhibition: the role of autophagy and glutathione homeostasis.
    Casarejos MJ; Solano RM; Rodriguez-Navarro JA; Gómez A; Perucho J; Castaño JG; García de Yébenes J; Mena MA
    J Neurochem; 2009 Sep; 110(5):1523-37. PubMed ID: 19549073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glial dysfunction in parkin null mice: effects of aging.
    Solano RM; Casarejos MJ; Menéndez-Cuervo J; Rodriguez-Navarro JA; García de Yébenes J; Mena MA
    J Neurosci; 2008 Jan; 28(3):598-611. PubMed ID: 18199761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of L-dopa immunoreactivity in some neurons in the human mesencephalic region: a novel dopa neuron group?
    Komori K; Uesaka S; Yamaoka H; Fujita K; Yamaoka K; Naitoh H; Kuroda M; Karasawa N; Ito T; Kasahara Y
    Neurosci Lett; 1993 Jul; 157(1):13-6. PubMed ID: 8233022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Study on bisphenol A induced primary cultured mesencephalic neuronal cell injury by oxidative stress].
    Lin Y; Zeng XG; Wu DS; Wang X
    Wei Sheng Yan Jiu; 2006 Jul; 35(4):419-22. PubMed ID: 16986513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: role of neuron-glia crosstalk.
    Saavedra A; Baltazar G; Santos P; Carvalho CM; Duarte EP
    Neurobiol Dis; 2006 Sep; 23(3):533-42. PubMed ID: 16766196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurotrophic and neurotoxic effects of nitric oxide on fetal midbrain cultures.
    Canals S; Casarejos MJ; Rodríguez-Martín E; de Bernardo S; Mena MA
    J Neurochem; 2001 Jan; 76(1):56-68. PubMed ID: 11145978
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Depletion of intracellular glutathione increases susceptibility to nitric oxide in mesencephalic dopaminergic neurons.
    Ibi M; Sawada H; Kume T; Katsuki H; Kaneko S; Shimohama S; Akaike A
    J Neurochem; 1999 Oct; 73(4):1696-703. PubMed ID: 10501217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures.
    McNaught KS; Jenner P
    J Neurochem; 1999 Dec; 73(6):2469-76. PubMed ID: 10582607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glutathione depletion switches nitric oxide neurotrophic effects to cell death in midbrain cultures: implications for Parkinson's disease.
    Canals S; Casarejos MJ; de Bernardo S; Rodríguez-Martín E; Mena MA
    J Neurochem; 2001 Dec; 79(6):1183-95. PubMed ID: 11752059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adeno-associated virus-mediated gene transfer of human aromatic L-amino acid decarboxylase protects mixed striatal primary cultures from L-DOPA toxicity.
    Doroudchi MM; Liauw J; Heaton K; Zhen Z; Forsayeth JR
    J Neurochem; 2005 May; 93(3):634-40. PubMed ID: 15836622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures.
    Mercer LD; Kelly BL; Horne MK; Beart PM
    Biochem Pharmacol; 2005 Jan; 69(2):339-45. PubMed ID: 15627486
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Astrocytes protect MN9D neuronal cells against rotenone-induced oxidative stress by a glutathione-dependent mechanism.
    Cao Q; Wei LR; Lu LL; Zhao CL; Zhao HY; Yang H
    Sheng Li Xue Bao; 2007 Jun; 59(3):253-9. PubMed ID: 17579777
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological approaches to counter the toxicity of Dopa.
    VonVoigtlander PF; Fici GJ; Althaus JS
    Amino Acids; 1998; 14(1-3):189-96. PubMed ID: 9871460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.
    Offen D; Sherki Y; Melamed E; Fridkin M; Brenneman DE; Gozes I
    Brain Res; 2000 Jan; 854(1-2):257-62. PubMed ID: 10784133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.